Clinical trial
Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV…
NCT00084136 · Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, Other · Completed
Key facts
| NCT number | NCT00084136 |
|---|---|
| Title | Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings |
| Official title | Randomized, Open-Label Evaluation of Efficacy of Once-Daily Protease Inhibitor and Once-Daily Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Therapy Combinations for Initial Treatment of HIV-1 Infected Persons From Resource-Limited Settings (PEARLS) Trial |
| Acronym | PEARLS |
| Lead sponsor | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, Other |
| Collaborators | National Institute of Allergy and Infectious Diseases (NIAID) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Atazanavir, Didanosine (enteric-coated), Efavirenz, Emtricitabine, Emtricitabine/Tenofovir disoproxil fumarate, Lamivudine/Zidovudine |
| Enrollment | 1,571 |
| Start date | May 1, 2005 |
| Primary completion | May 1, 2010 |
| Completion | May 1, 2010 |
| First posted | Jun 8, 2004 |
| Last update posted | Oct 10, 2018 |
| Countries | Brazil, Haiti, India, Malawi, Peru, South Africa, Thailand, United States, Zimbabwe |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: